Are There Changes Ahead for the Generalized Anxiety Disorder Market?Decision ResourcesJanuary 26, 2009 21 Pages - SKU: DECR2118822 |
|
Brain Hemorrhage Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Brain Hemorrhage Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H1, 2012 provides data on the Brain Hemorrhage clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Brain Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Brain Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Brain Injury Global Clinical Trials Review, H1, 2012 provides data on the Brain Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012 provides data on the Cerebral Infarction (Brain Infarction) clinical trial scenario. This
|
more...
|
$1,000.00
|
|
Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Cluster Headache Global Clinical Trials Review, H1, 2012 provides data on the Cluster Headache clinical trial scenario. This report provides elemental information and
|
more...
|
$1,000.00
|
|
Tension -Type Headache Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Tension -Type Headache Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Tension -Type Headache Global Clinical Trials Review, H1, 2012 provides data on the Tension -Type Headache clinical trial scenario. This report provides elemental
|
more...
|
$1,000.00
|
|
Traumatic Brain Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Traumatic Brain Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Traumatic Brain Injury Global Clinical Trials Review, H1, 2012 provides data on the Traumatic Brain Injury clinical trial scenario. This report provides elemental
|
more...
|
$1,000.00
|
|
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2012 provides data on the Amyotrophic Lateral Sclerosis clinical trial scenario. This report provides elemental
|
more...
|
$1,000.00
|
|
Brain Ischemia Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Brain Ischemia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Brain Ischemia Global Clinical Trials Review, H1, 2012 provides data on the Brain Ischemia clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion
4/30/2012 | published by: GBI Research
Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion Summary GBI Research, the leading business intelligence provider, has released its latest research, “Cytotoxic Therapies Market
|
more...
|
$3,500.00
|
|
Top 194 Generic Pharmaceuticals (Global)
4/1/2012 | published by: Plimsoll Publishing Ltd.
This report is an in-depth financial evaluation of the GlobalGeneric Pharmaceuticals. Using the unique Plimsoll method of analysis, each of the top 194 companies included is individually assessed and ranked against each other and compared
|
more...
|
$1,500.00
|
Related Markets
Behavioral Health Reports
- Key Companies: Depression - Leading players must adapt to remain competitive
- CNS Market Access in China - Investment in mental health services offers growth opportunities for psychiatry players
- Product Profiles: Depression - Next generation vies for second-line patients
- Alcohol Addiction Global Clinical Trials Review, Q2, 2011
- Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D are Major Concerns
